Shockwave Therapy Market By Technique (Electrohydraulic Technique, Piezoelectric Technique, Radial Technique, Electromagnetic Shock Waves), By Product (Mobile Shockwave Therapy Devices, Fixed Shockwave Therapy Devices), By Application (Orthopedics, Cardiology, Urology, Others), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The shockwave therapy market was valued for $1,171.19 million in 2021 and is estimated to reach $2,269.63 million by 2031, exhibiting a CAGR of 6.8% from 2022 to 2031. Shockwave therapy is a non-invasive treatment that involves creating a series of low-energy acoustic wave pulsations that are directly applied to an injury through a person’s skin via a gel medium. It can relieve pain and promote the healing of injured tendons, ligaments, and other soft tissues. These sound waves produce a therapeutic effect that causes a decrease in pain, thus increasing mobility and functionality by triggering the body's healing process. Shockwave therapy is sometimes referred to as extracorporeal pulse activation technology (EPAT).
The Food and Drug Administration has approved the use of extracorporeal shock wave therapy (ESWT) for the treatment of plantar fasciopathy and tendinopathy. However, multiple high-quality randomized clinical trials have provided substantial evidence that ESWT is a safe and effective noninvasive option for treating tendinopathy throughout the musculoskeletal system.
The key factor that drives the growth of the shockwave therapy market is the increase in the number of sports-tournament that are organized worldwide, which increases the number of sports-related injuries to a great extent. These sports injuries require speedy recovery along with faster pain relief. Moreover, rise in rates of bone diseases as well as an increase in the prevalence of musculoskeletal disorders such as arthritis, and the surge in the geriatric population are the major factors driving the growth of the market. For instance, according to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation. Furthermore, increased investments in R&D for the development of medical devices as well as rise in technological advancements and modernization in the healthcare industry may open up new market potential for shockwave therapy.
However, the high cost of the treatment by shockwave therapy and the side effects following the therapy hamper the market growth. Conversely, the surge in sedentary lifestyle practices in developing countries that are followed in the post-covid phase is giving rise to chronic spinal ailments and back problems, which provides lucrative opportunities for the growth of the market. In addition, an increase in the number of cardiovascular diseases as a result of sedentary lifestyle practices is expected to boost the growth of the market during the forecast period.
The shockwave therapy market is segmented on the basis of technology, type, application, end-user, and region. By technology, the market is fragmented into electrohydraulic shockwaves, electromagnetic shockwaves, piezoelectric shockwaves, and radial shockwaves. By product, it is bifurcated into mobile and fixed. By application, it is classified into urology, orthopedic, cardiology, and others. By end user, the market is categorized into hospitals, clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the shockwave therapy market share in 2021 and is anticipated to remain dominant during the forecast period. The shockwave therapy market is mainly driven by the presence of well-established healthcare facilities, a growing geriatric population, and the rising prevalence of sports-related injuries & cardiovascular disorders. Moreover, an increase in the prevalence of arthritis and musculoskeletal disorders contribute to the market growth in the region. Furthermore, increasing investment by pharmaceutical companies in R&D activities to design technologically advanced medical devices through innovative research is expected to fuel the market growth.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of a rapidly growing geriatric population, rising incidence of road accidents & chronic disorders, and improvement in the healthcare infrastructure are set to drive the market in Asia-Pacific.
The key players that operate in the shockwave therapy market are BioMed India, Boston Scientific Corporation, BTL Corporate, Dornier MedTech, EDAP TMS, EMS Dolorclast, Inceler Medikal Co. Ltd, Karl Storz SE & Co, SANUWAVE and SANUWAVE Health, Inc. and Shockwave Medical Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the shockwave therapy market analysis from 2021 to 2031 to identify the prevailing shockwave therapy market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the shockwave therapy market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global shockwave therapy market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technique
Electrohydraulic Technique
Piezoelectric Technique
Radial Technique
Electromagnetic Shock Waves
By Product
Mobile Shockwave Therapy Devices
Fixed Shockwave Therapy Devices
By End User
Hospitals
Clinics
Others
By Application
Urology
Others
Orthopedics
Cardiology
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
EDAP TMS
Bio-Med Inc.
Dornier MedTech
KARL STORZ SE & Co. KG
Boston Scientific Corporation
BTL Industries
Shockwave Medical, Inc
SANUWAVE & SANUWAVE Health, Inc
Inceler Medikal Co. Ltd.
EMS Dolorclast
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.1.1. Increasing incidence of muscle and tendon disorder and sports-related injuries
- 3.4.1.2. Rise in technological advancement
- 3.4.1.3. Rise in chronic and musculoskeletal disorder
- 3.4.2.Restraints
- 3.4.2.1. High cost of the treatment
- 3.4.3.Opportunities
- 3.4.3.1. High growth potential in developing economies
- 3.5.COVID-19 Impact Analysis on the market
- CHAPTER 4: SHOCKWAVE THERAPY MARKET, BY TECHNIQUE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2. Electrohydraulic Technique
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3. Piezoelectric Technique
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4. Radial Technique
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- 4.5. Electromagnetic Shock Waves
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
- CHAPTER 5: SHOCKWAVE THERAPY MARKET, BY PRODUCT
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2. Mobile Shockwave Therapy Devices
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3. Fixed Shockwave Therapy Devices
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- CHAPTER 6: SHOCKWAVE THERAPY MARKET, BY APPLICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2. Orthopedics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3. Cardiology
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4. Urology
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
- 6.5. Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market share analysis by country
- CHAPTER 7: SHOCKWAVE THERAPY MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2. Hospitals
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market share analysis by country
- 7.3. Clinics
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market share analysis by country
- 7.4. Others
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market share analysis by country
- CHAPTER 8: SHOCKWAVE THERAPY MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Technique
- 8.2.3 North America Market size and forecast, by Product
- 8.2.4 North America Market size and forecast, by Application
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Key market trends, growth factors and opportunities
- 8.2.6.1.2 Market size and forecast, by Technique
- 8.2.6.1.3 Market size and forecast, by Product
- 8.2.6.1.4 Market size and forecast, by Application
- 8.2.6.1.5 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Key market trends, growth factors and opportunities
- 8.2.6.2.2 Market size and forecast, by Technique
- 8.2.6.2.3 Market size and forecast, by Product
- 8.2.6.2.4 Market size and forecast, by Application
- 8.2.6.2.5 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Key market trends, growth factors and opportunities
- 8.2.6.3.2 Market size and forecast, by Technique
- 8.2.6.3.3 Market size and forecast, by Product
- 8.2.6.3.4 Market size and forecast, by Application
- 8.2.6.3.5 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Technique
- 8.3.3 Europe Market size and forecast, by Product
- 8.3.4 Europe Market size and forecast, by Application
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Key market trends, growth factors and opportunities
- 8.3.6.1.2 Market size and forecast, by Technique
- 8.3.6.1.3 Market size and forecast, by Product
- 8.3.6.1.4 Market size and forecast, by Application
- 8.3.6.1.5 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Key market trends, growth factors and opportunities
- 8.3.6.2.2 Market size and forecast, by Technique
- 8.3.6.2.3 Market size and forecast, by Product
- 8.3.6.2.4 Market size and forecast, by Application
- 8.3.6.2.5 Market size and forecast, by End User
- 8.3.6.3 UK
- 8.3.6.3.1 Key market trends, growth factors and opportunities
- 8.3.6.3.2 Market size and forecast, by Technique
- 8.3.6.3.3 Market size and forecast, by Product
- 8.3.6.3.4 Market size and forecast, by Application
- 8.3.6.3.5 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Key market trends, growth factors and opportunities
- 8.3.6.4.2 Market size and forecast, by Technique
- 8.3.6.4.3 Market size and forecast, by Product
- 8.3.6.4.4 Market size and forecast, by Application
- 8.3.6.4.5 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Key market trends, growth factors and opportunities
- 8.3.6.5.2 Market size and forecast, by Technique
- 8.3.6.5.3 Market size and forecast, by Product
- 8.3.6.5.4 Market size and forecast, by Application
- 8.3.6.5.5 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Key market trends, growth factors and opportunities
- 8.3.6.6.2 Market size and forecast, by Technique
- 8.3.6.6.3 Market size and forecast, by Product
- 8.3.6.6.4 Market size and forecast, by Application
- 8.3.6.6.5 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Technique
- 8.4.3 Asia-Pacific Market size and forecast, by Product
- 8.4.4 Asia-Pacific Market size and forecast, by Application
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Key market trends, growth factors and opportunities
- 8.4.6.1.2 Market size and forecast, by Technique
- 8.4.6.1.3 Market size and forecast, by Product
- 8.4.6.1.4 Market size and forecast, by Application
- 8.4.6.1.5 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Key market trends, growth factors and opportunities
- 8.4.6.2.2 Market size and forecast, by Technique
- 8.4.6.2.3 Market size and forecast, by Product
- 8.4.6.2.4 Market size and forecast, by Application
- 8.4.6.2.5 Market size and forecast, by End User
- 8.4.6.3 Australia
- 8.4.6.3.1 Key market trends, growth factors and opportunities
- 8.4.6.3.2 Market size and forecast, by Technique
- 8.4.6.3.3 Market size and forecast, by Product
- 8.4.6.3.4 Market size and forecast, by Application
- 8.4.6.3.5 Market size and forecast, by End User
- 8.4.6.4 India
- 8.4.6.4.1 Key market trends, growth factors and opportunities
- 8.4.6.4.2 Market size and forecast, by Technique
- 8.4.6.4.3 Market size and forecast, by Product
- 8.4.6.4.4 Market size and forecast, by Application
- 8.4.6.4.5 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Key market trends, growth factors and opportunities
- 8.4.6.5.2 Market size and forecast, by Technique
- 8.4.6.5.3 Market size and forecast, by Product
- 8.4.6.5.4 Market size and forecast, by Application
- 8.4.6.5.5 Market size and forecast, by End User
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Key market trends, growth factors and opportunities
- 8.4.6.6.2 Market size and forecast, by Technique
- 8.4.6.6.3 Market size and forecast, by Product
- 8.4.6.6.4 Market size and forecast, by Application
- 8.4.6.6.5 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Technique
- 8.5.3 LAMEA Market size and forecast, by Product
- 8.5.4 LAMEA Market size and forecast, by Application
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Key market trends, growth factors and opportunities
- 8.5.6.1.2 Market size and forecast, by Technique
- 8.5.6.1.3 Market size and forecast, by Product
- 8.5.6.1.4 Market size and forecast, by Application
- 8.5.6.1.5 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Key market trends, growth factors and opportunities
- 8.5.6.2.2 Market size and forecast, by Technique
- 8.5.6.2.3 Market size and forecast, by Product
- 8.5.6.2.4 Market size and forecast, by Application
- 8.5.6.2.5 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Key market trends, growth factors and opportunities
- 8.5.6.3.2 Market size and forecast, by Technique
- 8.5.6.3.3 Market size and forecast, by Product
- 8.5.6.3.4 Market size and forecast, by Application
- 8.5.6.3.5 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Key market trends, growth factors and opportunities
- 8.5.6.4.2 Market size and forecast, by Technique
- 8.5.6.4.3 Market size and forecast, by Product
- 8.5.6.4.4 Market size and forecast, by Application
- 8.5.6.4.5 Market size and forecast, by End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Top player positioning, 2021
- CHAPTER 10: COMPANY PROFILES
- 10.1 EDAP TMS
- 10.1.1 Company overview
- 10.1.2 Key Executives
- 10.1.3 Company snapshot
- 10.1.4 Operating business segments
- 10.1.5 Product portfolio
- 10.1.6 Business performance
- 10.1.7 Key strategic moves and developments
- 10.2 Bio-Med Inc.
- 10.2.1 Company overview
- 10.2.2 Key Executives
- 10.2.3 Company snapshot
- 10.2.4 Operating business segments
- 10.2.5 Product portfolio
- 10.2.6 Business performance
- 10.2.7 Key strategic moves and developments
- 10.3 Dornier MedTech
- 10.3.1 Company overview
- 10.3.2 Key Executives
- 10.3.3 Company snapshot
- 10.3.4 Operating business segments
- 10.3.5 Product portfolio
- 10.3.6 Business performance
- 10.3.7 Key strategic moves and developments
- 10.4 KARL STORZ SE & Co. KG
- 10.4.1 Company overview
- 10.4.2 Key Executives
- 10.4.3 Company snapshot
- 10.4.4 Operating business segments
- 10.4.5 Product portfolio
- 10.4.6 Business performance
- 10.4.7 Key strategic moves and developments
- 10.5 Boston Scientific Corporation
- 10.5.1 Company overview
- 10.5.2 Key Executives
- 10.5.3 Company snapshot
- 10.5.4 Operating business segments
- 10.5.5 Product portfolio
- 10.5.6 Business performance
- 10.5.7 Key strategic moves and developments
- 10.6 BTL Industries
- 10.6.1 Company overview
- 10.6.2 Key Executives
- 10.6.3 Company snapshot
- 10.6.4 Operating business segments
- 10.6.5 Product portfolio
- 10.6.6 Business performance
- 10.6.7 Key strategic moves and developments
- 10.7 Shockwave Medical, Inc
- 10.7.1 Company overview
- 10.7.2 Key Executives
- 10.7.3 Company snapshot
- 10.7.4 Operating business segments
- 10.7.5 Product portfolio
- 10.7.6 Business performance
- 10.7.7 Key strategic moves and developments
- 10.8 SANUWAVE & SANUWAVE Health, Inc
- 10.8.1 Company overview
- 10.8.2 Key Executives
- 10.8.3 Company snapshot
- 10.8.4 Operating business segments
- 10.8.5 Product portfolio
- 10.8.6 Business performance
- 10.8.7 Key strategic moves and developments
- 10.9 Inceler Medikal Co. Ltd.
- 10.9.1 Company overview
- 10.9.2 Key Executives
- 10.9.3 Company snapshot
- 10.9.4 Operating business segments
- 10.9.5 Product portfolio
- 10.9.6 Business performance
- 10.9.7 Key strategic moves and developments
- 10.10 EMS Dolorclast
- 10.10.1 Company overview
- 10.10.2 Key Executives
- 10.10.3 Company snapshot
- 10.10.4 Operating business segments
- 10.10.5 Product portfolio
- 10.10.6 Business performance
- 10.10.7 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 2. SHOCKWAVE THERAPY MARKET FOR ELECTROHYDRAULIC TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 3. SHOCKWAVE THERAPY MARKET FOR PIEZOELECTRIC TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 4. SHOCKWAVE THERAPY MARKET FOR RADIAL TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 5. SHOCKWAVE THERAPY MARKET FOR ELECTROMAGNETIC SHOCK WAVES, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 6. GLOBAL SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 7. SHOCKWAVE THERAPY MARKET FOR MOBILE SHOCKWAVE THERAPY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 8. SHOCKWAVE THERAPY MARKET FOR FIXED SHOCKWAVE THERAPY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 9. GLOBAL SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. SHOCKWAVE THERAPY MARKET FOR ORTHOPEDICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. SHOCKWAVE THERAPY MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. SHOCKWAVE THERAPY MARKET FOR UROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. SHOCKWAVE THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. GLOBAL SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. SHOCKWAVE THERAPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. SHOCKWAVE THERAPY MARKET FOR CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. SHOCKWAVE THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. SHOCKWAVE THERAPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. U.S. SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. U.S. SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. U.S. SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. U.S. SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. CANADA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. CANADA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. CANADA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. CANADA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. MEXICO SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. MEXICO SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. MEXICO SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. MEXICO SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. EUROPE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. EUROPE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. EUROPE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. EUROPE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. EUROPE SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. GERMANY SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. GERMANY SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. GERMANY SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. GERMANY SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. FRANCE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. FRANCE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. FRANCE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. FRANCE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. UK SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. UK SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. UK SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. UK SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. ITALY SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. ITALY SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. ITALY SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. ITALY SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. SPAIN SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. SPAIN SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. SPAIN SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. SPAIN SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 70. JAPAN SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 71. JAPAN SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 72. JAPAN SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 73. JAPAN SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 74. CHINA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 75. CHINA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 76. CHINA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 77. CHINA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 78. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 79. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 80. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 81. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 82. INDIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 83. INDIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 84. INDIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 85. INDIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 86. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 87. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 88. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 89. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 90. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 91. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 92. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 93. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 94. LAMEA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 95. LAMEA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 96. LAMEA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 97. LAMEA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 98. LAMEA SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 99. BRAZIL SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 100. BRAZIL SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 101. BRAZIL SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 102. BRAZIL SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 103. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 104. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 105. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 106. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 107. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 108. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 109. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 110. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 111. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 112. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 113. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 114. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 115. EDAP TMS: KEY EXECUTIVES
- TABLE 116. EDAP TMS: COMPANY SNAPSHOT
- TABLE 117. EDAP TMS: OPERATING SEGMENTS
- TABLE 118. EDAP TMS: PRODUCT PORTFOLIO
- TABLE 119. EDAP TMS: NET SALES
- TABLE 120. EDAP TMS: KEY STRATERGIES
- TABLE 121. BIO-MED INC.: KEY EXECUTIVES
- TABLE 122. BIO-MED INC.: COMPANY SNAPSHOT
- TABLE 123. BIO-MED INC.: OPERATING SEGMENTS
- TABLE 124. BIO-MED INC.: PRODUCT PORTFOLIO
- TABLE 125. BIO-MED INC.: NET SALES
- TABLE 126. BIO-MED INC.: KEY STRATERGIES
- TABLE 127. DORNIER MEDTECH: KEY EXECUTIVES
- TABLE 128. DORNIER MEDTECH: COMPANY SNAPSHOT
- TABLE 129. DORNIER MEDTECH: OPERATING SEGMENTS
- TABLE 130. DORNIER MEDTECH: PRODUCT PORTFOLIO
- TABLE 131. DORNIER MEDTECH: NET SALES
- TABLE 132. DORNIER MEDTECH: KEY STRATERGIES
- TABLE 133. KARL STORZ SE & CO. KG: KEY EXECUTIVES
- TABLE 134. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
- TABLE 135. KARL STORZ SE & CO. KG: OPERATING SEGMENTS
- TABLE 136. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
- TABLE 137. KARL STORZ SE & CO. KG: NET SALES
- TABLE 138. KARL STORZ SE & CO. KG: KEY STRATERGIES
- TABLE 139. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 140. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 141. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 142. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 143. BOSTON SCIENTIFIC CORPORATION: NET SALES
- TABLE 144. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 145. BTL INDUSTRIES: KEY EXECUTIVES
- TABLE 146. BTL INDUSTRIES: COMPANY SNAPSHOT
- TABLE 147. BTL INDUSTRIES: OPERATING SEGMENTS
- TABLE 148. BTL INDUSTRIES: PRODUCT PORTFOLIO
- TABLE 149. BTL INDUSTRIES: NET SALES
- TABLE 150. BTL INDUSTRIES: KEY STRATERGIES
- TABLE 151. SHOCKWAVE MEDICAL, INC: KEY EXECUTIVES
- TABLE 152. SHOCKWAVE MEDICAL, INC: COMPANY SNAPSHOT
- TABLE 153. SHOCKWAVE MEDICAL, INC: OPERATING SEGMENTS
- TABLE 154. SHOCKWAVE MEDICAL, INC: PRODUCT PORTFOLIO
- TABLE 155. SHOCKWAVE MEDICAL, INC: NET SALES
- TABLE 156. SHOCKWAVE MEDICAL, INC: KEY STRATERGIES
- TABLE 157. SANUWAVE & SANUWAVE HEALTH, INC: KEY EXECUTIVES
- TABLE 158. SANUWAVE & SANUWAVE HEALTH, INC: COMPANY SNAPSHOT
- TABLE 159. SANUWAVE & SANUWAVE HEALTH, INC: OPERATING SEGMENTS
- TABLE 160. SANUWAVE & SANUWAVE HEALTH, INC: PRODUCT PORTFOLIO
- TABLE 161. SANUWAVE & SANUWAVE HEALTH, INC: NET SALES
- TABLE 162. SANUWAVE & SANUWAVE HEALTH, INC: KEY STRATERGIES
- TABLE 163. INCELER MEDIKAL CO. LTD.: KEY EXECUTIVES
- TABLE 164. INCELER MEDIKAL CO. LTD.: COMPANY SNAPSHOT
- TABLE 165. INCELER MEDIKAL CO. LTD.: OPERATING SEGMENTS
- TABLE 166. INCELER MEDIKAL CO. LTD.: PRODUCT PORTFOLIO
- TABLE 167. INCELER MEDIKAL CO. LTD.: NET SALES
- TABLE 168. INCELER MEDIKAL CO. LTD.: KEY STRATERGIES
- TABLE 169. EMS DOLORCLAST: KEY EXECUTIVES
- TABLE 170. EMS DOLORCLAST: COMPANY SNAPSHOT
- TABLE 171. EMS DOLORCLAST: OPERATING SEGMENTS
- TABLE 172. EMS DOLORCLAST: PRODUCT PORTFOLIO
- TABLE 173. EMS DOLORCLAST: NET SALES
- TABLE 174. EMS DOLORCLAST: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1. SEGMENTATION OF SHOCKWAVE THERAPY MARKET,2021-2031
- FIGURE 2. SHOCKWAVE THERAPY MARKET,2021-2031
- FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 4. PORTER FIVE-1
- FIGURE 5. PORTER FIVE-2
- FIGURE 6. PORTER FIVE-3
- FIGURE 7. PORTER FIVE-4
- FIGURE 8. PORTER FIVE-5
- FIGURE 9. SHOCKWAVE THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 10. SHOCKWAVE THERAPY MARKET,BY TECHNIQUE,2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ELECTROHYDRAULIC TECHNIQUE SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PIEZOELECTRIC TECHNIQUE SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF RADIAL TECHNIQUE SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ELECTROMAGNETIC SHOCK WAVES SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 15. SHOCKWAVE THERAPY MARKET,BY PRODUCT,2021(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MOBILE SHOCKWAVE THERAPY DEVICES SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FIXED SHOCKWAVE THERAPY DEVICES SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 18. SHOCKWAVE THERAPY MARKET,BY APPLICATION,2021(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDICS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CARDIOLOGY SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF UROLOGY SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF OTHERS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 23. SHOCKWAVE THERAPY MARKET,BY END USER,2021(%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HOSPITALS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CLINICS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 26. COMPARATIVE SHARE ANALYSIS OF OTHERS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
- FIGURE 27. SHOCKWAVE THERAPY MARKET BY REGION,2021
- FIGURE 28. U.S. SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 29. CANADA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 30. MEXICO SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 31. GERMANY SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 32. FRANCE SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 33. UK SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 34. ITALY SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 35. SPAIN SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 36. REST OF EUROPE SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 37. JAPAN SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 38. CHINA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 39. AUSTRALIA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 40. INDIA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
- FIGURE 41. SOUTH KOREA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook